Liletta® (levonorgestrel-releasing intrauterine system) – New indication
June 29, 2023 - The FDA approved AbbVie’s Liletta (levonorgestrel-releasing intrauterine system), for the treatment of heavy menstrual bleeding for up to 5 years in patients who choose to use intrauterine contraception as their method of contraception.
Top